本页面由Tiger Trade Technology Pte. Ltd.提供服务

Psyence Biomedical Ltd

4.63
-0.1104-2.33%
成交量:2.69万
成交额:12.50万
市值:1,765.87万
市盈率:-0.37
高:4.79
开:4.70
低:4.60
收:4.74
52周最高:22.96
52周最低:1.92
股本:381.43万
流通股本:109.46万
量比:1.47
换手率:2.46%
股息:- -
股息率:- -
每股收益(TTM):-12.5596
每股收益(LYR):-12.5596
净资产收益率:-58.62%
总资产收益率:-31.33%
市净率:1.04
市盈率(LYR):-0.37

数据加载中...

2024/11/12

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

SEC问询函

Form CORRESP - Correspondence
2024/10/30

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/10/08

SEC问询函

Form CORRESP - Correspondence
2024/10/02

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/08/27

SEC问询函

Form CORRESP - Correspondence
2024/08/20

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/07/31

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/27

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/05/13

SEC问询函

Form CORRESP - Correspondence
2024/05/10

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/09

SEC问询函

Form CORRESP - Correspondence
2024/05/07

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/06

SEC问询函

Form CORRESP - Correspondence
2024/04/18

SEC问询函

Form CORRESP - Correspondence
2024/04/18

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/02/10

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/02/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/01/31

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]